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Introduction:
Metallic implants are often used for fracture fixation. However, 
stress-shielding effect may be resulted in some cases and thereby 
leading to bone loss around the implant1. Therefore those metallic
implants may need to be removed after the tissues have healed. The 
use of degradable metallic materials such as magnesium alloy is a 
promising candidate that may avoid second surgery. Hence, it helps
reduce costs to health care system and morbidity to the patients. 
However, the major obstacles are the rapid degradation inside the 
human body and hydrogen gas release upon degradation. The 
corrosion rate has to be carefully controlled so as to make the alloys 
available for orthopaedic implantation. Surface modification is used
since this method will not alter the bulk properties of magnesium 
alloy. Various surface treatments such as Plasma Immersion Ion 
Implantation and Deposition (PIII&D)2 and plasma anodisation3 are 
applied so that the corrosion resistance of material can be enhanced. 
Our group has recently developed a unique method to deposit a
biodegradable polymer named polycaprolactone (PCL) on the 
magnesium surface. Previous in-vitro studies suggested that the rate 
of degradation of the magnesium alloy has been delayed. Hence, this 
study aims to investigate the degradation and new bone formation of 
the coated magnesium alloy under in-vivo conditions.
Methods:
Polymer treated magnesium alloy was prepared by gas spraying. 
The polymer solution was prepared by dissolving the PCL granules 
into a solvent called dichloromethane. Two concentrations named 
PCL1 and PCL2 were prepared by dissolving 1g of polymer granules 
into 20ml and 30ml solvent respectively.
Two of each PCL1, PCL2 and untreated AZ91 magnesium alloy 
with 3mm diameter and 6mm long were then implanted into the great 
trochanter of three New Zealand White rabbits respectively. The 
animals were sacrificed at the second month of post-operation. The 
bone tissues with implants were harvested and fixed in 10% buffered 
formalin. All the samples were then embedded in methyl-methacrylate. 
The corrosion morphology and sectioning of the implants were 
examined by micro-computed tomography. After scanning by micro-
CT, 2D planes were reconstructed by using NRecon software 
(Skyscan Company) and the 3D models were generated by CTVol
which was a program for realistic 3D visualization. The total volume 
of implanted magnesium rod and new bone volume were calculated 
by using CTAn program which was used to analyze micro-CT 
datasets for morphometry and densitometry. Afterwards, the 
embedded tissue blocks were sectioned and ground to 50µm. Gimesa 
staining was then applied to the slides for histological analysis. The 
on-growth of new bone and the integration of material to host tissue
were observed under optical microscope.
Results: 
From the reconstruction images as shown in Figure 1, corrosion 
was found on untreated samples (red arrows) but not observed on 
PCL1 and PCL2 samples. By observing the 3D reconstruction models 
as shown in Figure 2, all the samples demonstrated the new bone
formation on the material surface (white in colour). The actual values 
of the remaining implant volume and newly formed bone volume 
were displayed on Table 1. By comparing the treated and untreated 
samples, the untreated magnesium alloy showed the least volume of 
new bone formation and largest volume reduction of the implant after 
2 months implantation, whereas PCL2 sample has the highest bone 
volume. The histological analysis confirmed that the newly formed 
bone tissue was observed around all of the implants. New bone 
(yellow arrows) and osteoblasts (green arrows) were observed in 
Figure 3.
Discussion:
In order to visualize the corrosion morphology and to quantify 
the in-vivo corrosion rate, micro-CT scan was employed. The micro-
CT images showed that both PCL1 and PCL2 coatings were able to 
protect the magnesium alloy even under in-vivo conditions. Moreover, 
with the use of micro-CT, the volume changes of all samples were 
quantified. The result suggested that the untreated implant had the 
fastest corrosion rate but the polymer treated samples showed no 
degradation at two months time point.
Furthermore, bone formation could also be observed and 
quantified by using micro-CT analysis. Newly formed bone was 
found around the implants of both treated and untreated samples in 
which these observations proved their biocompatibility. No adverse 
effect was found after implantation. Although corrosion occurred on 
the untreated sample, new bone formation was still observed around 
the implant. The result was found to be comparable with others’
findings. Both Witte et al.4 and Xu et al.5 suggested that although 
corrosion occurred on their magnesium based alloys, newly bone 
formation was found around the implant. However, by comparing the 
new bone volumes in our present experiment, it was found that the 
untreated sample got the least amount of new bone formation than the 
treated samples. This was mainly related to the magnesium ion release. 
As demonstrated in the pervious in-vitro cytotoxicity test, the 
osteoblastic activity was affected by the magnesium ion concentration. 
During corrosion, large amount of magnesium ion released may 
inactivate new bone formation. Therefore less new bone was formed 
around the untreated sample. 
For the histological analysis, since gimesa also contained eosin, 
apart from staining nucleus, cytoplasm could be stained as well. For 
the area that was purple in colour was the mixture of blue and red 
colours, it represented the new bone growth area. Moreover, large 
amount of osteoblast was found around the polymer treated samples 
which led to more bone formation. Furthermore, no inflammation was 
found around the implants which suggested that no harmful effect 
occurred to the surroundings. 
From the in-vivo animal study, it could be concluded that the 
polymer treated magnesium alloy was able to improve the corrosion 
resistance properties of the magnesium alloy significantly. Although 
the preliminary animal study showed successful result, longer time 
point is still needed so as to confirm the effectiveness and the 
degradation rate of the polymer coating with longer implantation time.
Table 1. Values of the new bone volume and the remaining implant volume
Figure 1. Micro-CT image of the implants after reconstruction. (a) untreated; 
(b) PCL1  and (2) PCL2
Figure 2. 3D model of the implants with newly formed bone. (a) Untreated; (b) 
PCL1 and (c) PCL2
Figure 3. Histological photographs of gimesa stained of the bone tissue formed 
around the implants. (a) Untreated; (b) PCL1 and (c) PCL2
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Sample New bone volume Implant volume change
Untreated 1.36 mm3 0.33%
PCL1 6.71 mm3 0
PCL2 10.79 mm3 0
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